Gabor-based visual training for adults with amblyopia
Official title: A Randomized Controlled Trial of Gabor-Based Perceptual Learning for Adult Amblyopia
Run by Shanghai Eye Disease Prevention and Treatment Center · NCT07764198 · Data updated 2026-11-12
This study tests a computer-based Gabor training program to see if it can improve vision in adults aged 18–39 with amblyopia due to anisometropia or strabismus.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 39 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Shanghai Eye Disease Prevention and Treatment Center Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | May 25, 2025 |
| Main results expected | October 2026 |
| Study ends | December 2026 |
| Registry record updated | August 13, 2026 |
| Trial ID | NCT07764198 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–39 with amblyopia due to anisometropia, strabismus, or both, who have completed optical correction and a stability period and can use the home training device.
✕Probably not a fit
Some participants may not experience meaningful vision improvement despite training, especially if amblyopia is non-responsive to perceptual learning.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, interventional study uses Gabor-based perceptual learning powered by RevitalVision software to train visual processing at home. Eligible adults with amblyopia will complete an optical correction period and then undergo repetitive visual tasks near their perception threshold to improve eye-brain coordination. The program runs on a home device, and outcomes will be compared to a control approach to determine any vision gains. The trial is conducted at the Shanghai Eye Disease Prevention and Treatment Center in Shanghai, with primary focus on adults who meet specific anisometropia and strabismus criteria. No collaborators are listed beyond the lead sponsor.
Why it matters
Potential benefit: If successful, participants may experience improved visual acuity and stereo function through a noninvasive training program.
How similar studies have gone: Previous studies in adults have shown that perceptual learning can yield vision gains in amblyopia, supporting the approach but results can vary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria 1. Written informed consent; age 18-39 years inclusive at randomization. 2. Diagnosis of amblyopia, with amblyopic-eye BCVA of approximately 20-70 ETDRS letters (approximately decimal BCVA 0.05-0.6). 3. Amblyopia caused by anisometropia, strabismus, or both, meeting the following definitions: Anisometropic amblyopia: interocular spherical-equivalent difference ≥1.00 D or astigmatic difference ≥1.50 D in any meridian, with no manifest strabismus at distance or near. Strabismic amblyopia: strabismus at distance or near, or a history of strabismus surgery, without meeting the anisometropia criterion. Combined-mechanism amblyopia: meeting both the strabismus and anisometropia criteria. 4. Completion of standardized optical correction and the 8-12-week stability period; absolute difference between week -4 and week 0 ETDRS scores \<5 letters, with no continuing pretreatment improvement trend. 5. Ability to use the study device for home training and accept electronic adherence monitoring. Exclusion Criteria 1. Eccentric fixation, clinically significant nystagmus, or inability to complete reliable ETDRS testing. 2. Corneal, lenticular, retinal, macular, optic-nerve, or neurologic disease capable of explaining the visual-acuity reduction. 3. Study-eye spherical equivalent \<-8.00 D, or high refractive error judged by the investigator to compromise test reliability. 4. Recent intraocular surgery or ocular trauma, or extraocular-muscle surgery considered likely to affect outcomes. 5. Diplopia at baseline that interferes with safety evaluation, or an unacceptable training risk as judged by the investigator. 6. Patching, penalization, other visual training, or treatment likely to affect amblyopia outcomes within the prespecified period before randomization. 7. Inability to complete follow-up, understand the tasks, or participation in another clinical study likely to affect outcomes.
Where it's running
-
Shanghai Eye Disease Prevention and Treatment Center
Shanghai, China Recruiting
Study contacts
- Study coordinator: Yan Xu
- Email: drxuyan_2004@163.com
- Phone: 021-62982727-856
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Psilocybin-assisted therapy to help adults with amblyopia see more clearly
This study tests whether a single or small doses of psilocybin can boost the effectiveness of amblyopia treatment in adults.
-
Augmented Reality Binocular Therapy for Adult Amblyopia
This trial tests a home-based augmented reality binocular therapy to see if it improves vision in adults 18–40 with anisometropic amblyopia, compared with placebo training.
-
Noninvasive brain stimulation plus augmented reality vision therapy for anisometropic amblyopia in adults
This trial tests whether adding HD-tDCS to AR-based dichoptic therapy can improve vision in adults with anisometropic amblyopia.
-
tDCS for paediatric amblyopia
This study tests whether non-invasive brain stimulation (tDCS) can improve vision for children aged 4–14 with amblyopia who didn’t get enough help from patching.
-
Targeted Lens Intervention for Anisometropia in Children
We’re testing if research spectacles can reduce the difference in prescription between a child’s eyes when one eye is more myopic than the other.
-
Gamified visual training with occlusion for kids with anisometropic amblyopia
This trial tests two kid-friendly digital games plus patching to see if they improve vision and motivation in children aged 4–7 with anisometropic amblyopia compared with patching alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.